BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Developments in Telemedicine: Influencing physicians at the point of care
 

Introduction

Telemedicine has the potential to transform the way healthcare is provided. With the aid of newer technologies, physicians and other healthcare providers can examine, treat and monitor patients remotely without compromising standards of care. 

Scope

50 interviews with physicians across six major pharmaceutical markets in Europe and the US. 

A detailed analysis of the various applications used in the delivery of telemedicine and the key factors slowing the adoption of such technologies 

An assessment of the impact of telemedicine on the patient care value chain: the services provided to a patient in the course of receiving healthcare 

An examination of the opportunities for pharmaceutical companies to take a role in the telemedicine market. 

Report Highlights

Pharmaceutical companies should prepare for the growth in the telemedicine market by partnering with medical device companies and technology vendors in markets with strong growth potential. 

The pharmaceutical industry must take collaborative steps towards providing clear and compelling evidence of the value proposition of telemedicine. 

Reasons to Purchase

Identify future trends in physician use of telemedicine applications. 

Recognize the variety of healthcare services telemedicine can deliver and recognize the potential benefits of its use. 

Understand how to overcome the key resistors in industry adoption. 

Publisher: Datamonitor eHealthcare Pharma Reports 

To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/Datamonitor_eHealthcare_Pharma.html#a42

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2008 - BioPortfolio Limited.